Literature DB >> 15065184

Chromosomal abnormalities in fetuses with open neural tube defects: prenatal identification with ultrasound.

W Sepulveda1, E Corral, C Ayala, C Be, J Gutierrez, P Vasquez.   

Abstract

OBJECTIVES: To determine the prevalence of chromosomal abnormalities in fetuses with open neural tube defects (NTD) undergoing prenatal chromosome analysis. The role of prenatal ultrasound in detecting those with an underlying chromosomal abnormality was also investigated.
METHODS: Over a 6-year period, 144 fetuses with open NTD underwent prenatal chromosome analysis between 12 and 37 weeks of gestation, as part of a prospective, multicenter prenatal diagnosis and counseling program in Chile. This population included 66 fetuses with spina bifida, 46 with acrania/anencephaly, 21 with cephalocele and 11 with iniencephaly. A confident prenatal diagnosis was made in 143 fetuses (99%) and confirmed postnatally in all cases.
RESULTS: An underlying chromosomal abnormality was diagnosed in 10 fetuses (7%), six with spina bifida, three with cephalocele and one with craniorachischisis. The prevalence of chromosomal abnormality varied according to the defect present in the fetus, with a 14% (3/21) prevalence among those with cephalocele, 9% (6/66) among those with spina bifida and 2% (1/57) among those with lethal defects such as acrania, anencephaly or iniencephaly. Karyotype results revealed trisomy 18 in seven cases, trisomy 13 in two and mosaicism for a marker chromosome in one. Prenatal ultrasound before the procedure showed that all chromosomally abnormal fetuses had additional findings. The prevalence of chromosomal abnormality in fetuses with spina bifida and cephalocele was higher when chromosome analysis was performed at or before 24 weeks of gestation in comparison to those performed after 24 weeks (5/31 (16%) vs. 4/56 (7%), respectively). However, this difference did not reach statistical significance, probably due to the small number of cases.
CONCLUSIONS: A significant number of fetuses with open NTD are chromosomally abnormal. Although prenatal chromosome analysis should be considered in all cases, prenatal ultrasound seems effective in identifying those fetuses with an underlying chromosomal abnormality. Copyright 2004 ISUOG.

Entities:  

Mesh:

Year:  2004        PMID: 15065184     DOI: 10.1002/uog.964

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  7 in total

Review 1.  Prenatal diagnosis of spina bifida: from intracranial translucency to intrauterine surgery.

Authors:  Waldo Sepulveda; Amy E Wong; Francisco Sepulveda; Juan L Alcalde; Juan C Devoto; Felipe Otayza
Journal:  Childs Nerv Syst       Date:  2017-06-07       Impact factor: 1.475

Review 2.  Fetal evaluation of spine dysraphism.

Authors:  Dorothy Bulas
Journal:  Pediatr Radiol       Date:  2010-04-30

3.  Prenatal diagnosis of acrania/exencephaly/anencephaly sequence (AEAS): additional structural and genetic anomalies.

Authors:  Julia Bijok; Sylwia Dąbkowska; Anna Kucińska-Chahwan; Diana Massalska; Beata Nowakowska; Sylwia Gawlik-Zawiślak; Grzegorz Panek; Tomasz Roszkowski
Journal:  Arch Gynecol Obstet       Date:  2022-05-12       Impact factor: 2.344

Review 4.  Fetal Brain Development: Regulating Processes and Related Malformations.

Authors:  Zvi Leibovitz; Tally Lerman-Sagie; Leila Haddad
Journal:  Life (Basel)       Date:  2022-05-29

5.  Fetal Pathology of Neural Tube Defects - An Overview of 68 Cases.

Authors:  Katharina Schoner; Roland Axt-Fliedner; Rainer Bald; Barbara Fritz; Juergen Kohlhase; Thomas Kohl; Helga Rehder
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-05-24       Impact factor: 2.915

Review 6.  Roles of planar cell polarity pathways in the development of neural [correction of neutral] tube defects.

Authors:  Gang Wu; Xupei Huang; Yimin Hua; Dezhi Mu
Journal:  J Biomed Sci       Date:  2011-08-24       Impact factor: 8.410

7.  Detection of copy number variants reveals association of cilia genes with neural tube defects.

Authors:  Xiaoli Chen; Yiping Shen; Yonghui Gao; Huizhi Zhao; Xiaoming Sheng; Jizhen Zou; Va Lip; Hua Xie; Jin Guo; Hong Shao; Yihua Bao; Jianliang Shen; Bo Niu; James F Gusella; Bai-Lin Wu; Ting Zhang
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.